Adjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients With Stage III Lung Cancer

Clinical trial NCT06656598 · RECRUITING

Trial details

NCT number: NCT06656598
Sponsor: Intergroupe Francophone de Cancerologie Thoracique
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Stage III NSCLC

Start date: 2025-11-07
Primary completion: 2028-09-01
Enrollment: 152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.